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OBJECTIVES We studied the expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell
adhesion molecule 1 (VCAM-1) and endothelial selectin (E-selectin) on aortic valve
endothelium in patients undergoing valve replacement. We also assessed the relation between
serum levels and endothelial expression and also the changes in serum levels following surgery.
BACKGROUND Nonrheumatic aortic valve disease is believed to be a degenerative condition. Increased tissue
and soluble adhesion molecule levels are described in inflammatory conditions.
METHODS Aortic valves from 22 surgical (16 bicuspid, 6 tricuspid) and 6 autopsy (4 normal, 2 thickened)
cases were studied by immunohistochemistry. Soluble adhesion molecules were measured in
peripheral blood preoperatively, and at 6 and 18 months postoperatively, and compared with
controls.
RESULTS The majority of the surgically removed tricuspid and bicuspid valves expressed adhesion
molecules (E-selectin, 75% and 100%; ICAM-1, 75% and 80%; VCAM-1, 69% and 60%,
respectively). The normal postmortem valves did not express these, while the diseased ones
did. Endothelial expression of E-selectin correlated strongly with serum levels (r 5 0.695,
p 5 0.004). Soluble E-selectin levels were significantly higher at baseline compared with
controls (p 5 0.017) and fell significantly at 18 months postoperatively (p 5 0.005).
CONCLUSIONS Adhesion molecule expression on diseased valves supports an inflammatory component in
“degenerative” aortic valve disease. The diseased valves may be the main source of elevated
soluble E-selectin in this condition as blood levels correlate with endothelial expression and
blood levels fall at 18 months postoperatively. (J Am Coll Cardiol 2000;36:2257–62) © 2000
by the American College of Cardiology
Nonrheumatic stenosis of bicuspid and tricuspid aortic
valves is the most common form of valvular heart disease in
adults in Western societies (1). It is generally believed to be
a degenerative condition resulting from mechanical stress
(2,3). We have previously reported elevated levels of soluble
cellular adhesion molecules (CAMs) in nonrheumatic aortic
stenosis (AS) of tricuspid valves, suggesting an inflamma-
tory response in this condition (4).
Adhesion between endothelial cells and circulating leu-
kocytes is a key initial event in targeting leukocytes to sites
of inflammation. Cellular adhesion molecules mediate the
adhesion of cells with other cells or components of the
extracellular matrix. They are expressed on vascular endo-
thelium and on immune and inflammatory cells and are
critical in targeting circulating leukocytes to sites of inflam-
mation, transmigration of leukocytes across vascular endo-
thelium and in immune effector functions. The adhesion
molecules intercellular adhesion molecule 1 (ICAM-1),
vascular cell adhesion molecule 1 (VCAM-1) and endothe-
lial selectin (E-selectin) are expressed on vascular endothe-
lium and serve as ligands for counter-receptors on circulat-
ing inflammatory cells. The extracellular or soluble portions
of CAMs are detectable at low levels in serum of healthy
people, and raised levels have been described in various
inflammatory conditions (5).
This study examines the expression of ICAM-1,
VCAM-1 and E-selectin on aortic valve (AV) endothelium
in patients with “degenerative” AV disease, assesses the
relation between soluble CAM levels and their endothelial
expression and also the effect of valve replacement surgery
on soluble CAM levels.
METHODS
Study population. Twenty-two patients undergoing AV
replacement for critical AV disease were included. Exclu-
sion criteria were evidence of rheumatic disease, endocardi-
tis and other coexisting valvular disease. All patients had a
detailed history and general medical examination. Echocardi-
ography and cardiac catheterization data were reviewed. The
mean age of the patients was 65 6 12.43 years; there were
15 men and 6 women. There were 16 tricuspid and 6
bileaflet valves. Seventeen patients had AS and five had AS
and AR. Four patients (18%) had hypertension and five
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(22%) were current smokers. Valves were examined grossly
immediately after surgical removal, and segments of the
valve were snap frozen in liquid nitrogen and stored at
280°C for immunohistochemistry.
Sixteen of these 22 patients had blood taken for soluble
CAM measurements preoperatively and at 6 and 18 months
postoperatively. The remaining six patients were excluded,
five because of angiographically demonstrated coronary
artery disease and one because of history of treated polymy-
algia rheumatica. Sixteen healthy volunteers age matched to
within five years and gender matched, with normal physical
examination, electrocardiogram and echocardiogram were
included as controls. Blood samples were centrifuged after
clotting at 3,500 rpm for 10 min, and serum was separated
and stored at 270°C for analysis.
For comparison purposes, six AVs from autopsies (mean
age, 63.7 6 9.1 years) were studied (four normal, two
thickened but not stenosed). These were collected within
48 h of death, previous studies having shown good preser-
vation of cell antigens up to three days (6).
ELISA. Soluble ICAM-1, VCAM-1 and E-selectin were
measured by enzyme-linked immunosorbent assay
(ELISA), using commercially available kits (R & D Systems
Ltd; Abingdon, United Kingdom). The assay uses a sand-
wich ELISA that involves the simultaneous reaction of the
antigen in the sample to two antibodies directed against
different epitopes on the antigen molecule. All samples were
analyzed in duplicate, and the mean of two readings was
used to calculate the results. The correlation between the
two sets of readings was excellent (r 5 0.985).
Immunohistochemistry. Cryostat sections 10 mm thick
were cut onto silane-coated slides. The primary antibodies
used were monoclonal mouse antibodies against human
ICAM-1 (Novocastra 1:200), human VCAM-1 (Novocas-
tra, 1:50) and human E-selectin (Novocastra, 1:40). Endo-
thelium was confirmed by antibodies to human CD34
(Dako, 1:20)/CD31 (Dako, 1:40). The secondary antibody
used was rabbit anti-mouse biotin-labeled antibody (Dako,
1:300). The avidin-biotin complex kit used was Vectastain
Elite ABC (Vector Laboratories).
The slides were stained immunohistochemically by the
indirect avidin-biotin complex immunoperoxidase tech-
nique. Sections were fixed in acetone-methanol for 10 min,
the slides were blocked with 3% hydrogen peroxide, washed
with trishydroxymethylaminomethane (TRIS) saline, incu-
bated with the primary antibody at 4°C for 24 h and then
washed again with TRIS saline. The biotin-labeled second-
ary antibody was applied for 30 min at room temperature,
followed by the avidin-biotin conjugate for 30 min. Diami-
nobenzidine tetrahydrochloride was used as the chromagen,
and the sections were counterstained with hematoxylin.
Reactive tonsils were used as positive controls, and negative
controls were by substitution of primary antibody with
TRIS buffer to abolish staining. Staining was graded semi-
quantitatively from 0 to 41 on the endothelium. Immuno-
histochemical stains were assessed independently by an
experienced observer who was blinded to patient details.
Staining of intensity 21 or higher was considered positive.
Statistical analysis. Quantitative data for soluble CAM
levels are presented as median and range. The Fisher exact
test was used to compare differences between independent
proportions. In investigating the associations of the inten-
sity of staining for the three adhesion molecules, pairwise
nonparametric correlation (Spearman’s) was employed. A
coefficient of linear correlation was calculated to measure
the strength of association between quantitative variables.
The nonparametric paired signed rank test was used to
compare the levels of soluble adhesion molecules for con-
trols, preoperatively and postoperatively with a Bonferroni-
type correction for multiple comparisons (p , 0.025 con-
sidered significant).
RESULTS
Endothelial adhesion molecule expression. Most of the
surgically removed valves stained positive for the three
adhesion molecules. One of the 22 valves did not have
adequate endothelial preservation. The results of staining
for the remaining 21 valves are summarized in Table 1.
Examples of staining of the valves are shown in Figures 1 to
3. In the surgical cases, there was no significant difference in
the proportions of valves staining positive for any of the
three molecules between the bicuspid and tricuspid groups
(Fisher exact test—ICAM-1, p 5 1.0; VCAM-1, p 5 1.0;
E-selectin: p 5 0.532).
There was good pairwise association between endothelial
expression of all three adhesion molecules (Spearman’s
Abbreviations and Acronyms
AR 5 aortic regurgitation
AS 5 aortic stenosis
AV 5 aortic valve
CAM(s) 5 cellular adhesion molecule(s)
ELISA 5 enzyme-linked immunosorbent assay
E-selectin 5 endothelial selectin
ICAM-1 5 intercellular adhesion molecule 1
TRIS 5 trishydroxymethylaminomethane
VCAM-1 5 vascular cell adhesion molecule 1
Table 1. Adhesion Molecule Expression on Aortic
Valve Endothelium
ICAM-
11
VCAM-
11
E-
selectin1
Surgical-tricuspid (n 5 16),
n (%)
12 (75) 11 (69) 12 (75)
Surgical-bicuspid (n 5 5),
n (%)
4 (80) 3 (60) 5 (100)
Autopsy-normal (n 5 4),
n (%)
0 (0) 0 (0) 0 (0)
Autopsy-thickened (n 5 2),
n (%)
2 (100) 2 (100) 2 (100)
ICAM-1 5 intercellular adhesion molecule 1; VCAM-1 5 vascular cell adhesion
molecule 1; E-selectin 5 endothelial selectin.
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correlation coefficient)—ICAM-1 and VCAM-1, r 5 0.68,
p 5 0.001; ICAM-1 and E-selectin, r 5 0.69, p 5 0.001;
E-selectin and VCAM-1, r 5 0.64, p 5 0.002. The four
normal autopsy valves were negative for all three adhesion
molecules, while the two thickened valves were positive for
the three molecules.
Correlation between endothelial and soluble adhesion
molecule levels. There was a strong association between
the intensity of endothelial staining and soluble molecule
levels for E-selectin but not for ICAM-1 or VCAM-1
(Table 2).
Soluble adhesion molecule levels. Soluble E-selectin lev-
els were higher at baseline in patients compared with
controls, were unchanged at six months postoperatively, but
were significantly lower at 18 months postoperatively (Fig.
4). Soluble ICAM-1 did not differ significantly between
patients and controls and showed a rise at six months and 18
months postoperatively. Soluble VCAM-1 did not differ
significantly between patients preoperatively and controls
and did not change significantly at 6 months and 18 months
postoperatively.
DISCUSSION
This study demonstrates for the first time, expression of the
endothelial adhesion molecules ICAM-1, VCAM-1 and
Figure 1. Surgically removed bicuspid stenotic aortic valve (A) staining
positive for CD34 demonstrating endothelium, and also staining for (B)
E-selectin; (C) negative control for this valve. Original magnification 3 50.
Scale bar 20 mm.
Figure 2. Positive staining for (A) ICAM-1 in a bicuspid stenotic aortic
valve, and for (B) VCAM-1 and (C) E-selectin in a patient with aortic
stenosis of a tricuspid valve. Original magnification 3 50. Scale bar 20 mm.
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E-selectin in nonrheumatic degenerative AV disease. Solu-
ble E-selectin levels in peripheral blood correlated well with
valvular endothelial expression. Soluble E-selectin levels
were higher in patients compared with controls and fell
significantly at 18 months postoperatively.
Mechanical stress has been proposed as a possible mech-
anism for the development of degenerative AV disease (2,3).
However, all AVs are subject to long-term mechanical
stress, and valvular calcification of tricuspid and even bicus-
pid AVs is not an inevitable consequence of aging (7). Thus,
Figure 3. Section of tricuspid aortic valve from a patient with aortic
stenosis showing (A) positive staining for CD34 while (B) demonstrates
negative staining for ICAM-1 and (C) demonstrates weak staining for
E-selectin in the same patient. Original magnification 3 50. Scale bar
20 mm.
Figure 4. Dotplots of the data for soluble adhesion molecule levels overlaid
with boxplots showing medians, 25th and 75th percentiles with values,
range (whiskers) and extreme values (circles for outliers, stars for extreme
outliers). (A) soluble E-selectin (sE-selectin), (B) soluble ICAM-1
(sICAM-1) and (C) soluble VCAM-1 (sVCAM-1).
Table 2. Correlation Between Soluble Adhesion Molecule
Levels and the Intensity of Staining on Valvular Endothelium
Variable Pairs r Value p Value
sE-selectin and endothelial E-selectin 0.695 0.004
sICAM-1 and endothelial ICAM-1 20.048 0.866
sVCAM-1 and endothelial VCAM-1 20.494 0.061
r 5 Spearman’s correlation coefficient; E-selectin 5 endothelial selectin; ICAM-1 5
intercellular adhesion molecule 1; VCAM-1 5 vascular cell adhesion molecule 1.
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even if mechanical stress is an initiating factor, other factors
may be important in initiation and subsequent disease
progression.
Changes in soluble adhesion molecules levels after valve
replacement. Elevated levels of the soluble ICAM-1,
VCAM-1 and E-selectin have been reported in a variety of
inflammatory disorders (5). Elevated soluble E-selectin
particularly has been thought to reflect systemic inflamma-
tory conditions. In our study looking at levels serially,
E-selectin levels were elevated at baseline compared with
controls, remained high at six months postoperatively and
fell significantly 18 months after surgery. This may suggest
that the postoperative inflammatory response does not settle
down until at least six months after surgery. The subsequent
fall in levels suggests that the diseased valve itself may have
been either the main source of elevated levels or the source
of cytokines that may activate endothelium and thereby
result in elevated levels. We did not find any previous
reports on long-term effects of either valve replacement or
coronary bypass surgery on soluble adhesion molecule levels.
Correlation of soluble adhesion molecule levels with
endothelial expression. Measurement of soluble CAMs in
peripheral blood presents a potentially attractive means of
assessing inflammatory activity and the state of endothelial
activation in a variety of disease processes. An understand-
ing of the relationship between expression of adhesion
molecules in affected tissue and soluble CAM levels is
therefore important in determining the status of soluble
adhesion molecules as markers of tissue adhesion molecule
expression. Soluble CAMs are known to be generated by at
least two mechanisms: enzymatic cleavage from the cell
surface and alternative splicing of messenger RNA (without
being expressed at cell surface) (8). Endothelial-selectin is
expressed only on activated endothelial cells, and soluble
E-selectin is generated only by enzymatic cleavage from cell
surface E-selectin (5). Therefore, on theoretical grounds,
there should be good correlation between serum levels and
tissue expression in nonrheumatic AS, in which the disease
process is relatively localized. Our findings support the
usefulness of soluble E-selectin levels to assess endothelial
activation in “degenerative” AV disease.
There was poor correlation between soluble ICAM-1
levels and ICAM-1 on valvular endothelium. ICAM-1 is
found on a variety of cell types, including leukocytes,
endothelium, epithelium and smooth muscle cells (5),
therefore sICAM-1 in serum has many potential sources of
origin. Soluble ICAM-1 can be generated by both enzy-
matic cleavage and alternative splicing, and it is possible that
the major source of sICAM-1 formation is alternative
splicing. Studies in vascular beds in mice and in patients
with inflammatory bowel disease did not demonstrate a
relationship between soluble ICAM-1 and endothelial ex-
pression of ICAM-1. Our results support the lack of
association between soluble ICAM-1 and endothelial ex-
pression of ICAM-1 (9,10). VCAM-1 is also expressed on
multiple cell types (5), and therefore, soluble VCAM-1
levels may not reliably reflect endothelial expression of the
molecule.
Adhesion molecule expression on valvular endothelium.
Adhesion molecule expression on diseased valves may play a
part in the initiation or progression of the disease process.
Adhesion molecule expression can be upregulated in re-
sponse to cytokines or because of hemodynamic forces. The
cytokines tumor necrosis factor alpha and interleukin-1 have
been shown to induce production of ICAM-1, VCAM-1
and E-selectin (11). In our study, there was a strong
association between the endothelial expression of all three
adhesion molecules. The biomechanical paradigm of endo-
thelial cell activation has not been as clearly delineated as
the humoral model (12). Human umbilical vein endothelial
cells exposed to steady unidirectional laminar shear stress in
vitro show a time-dependent increase in ICAM-1 expres-
sion, while VCAM-1 and E-selectin remain unchanged. In
contrast, humoral (cytokine and bacterial endotoxin) acti-
vation resulted in induction of all three adhesion molecules
in the same model (12–14). The effect that turbulent
pulsatile flow, as seen in AV disease, would have on
adhesion molecule expression is unknown. These consider-
ations suggest that the increased expression of adhesion
molecules on valvular endothelium that we observed is more
likely to be cytokine induced rather than due to shear forces.
This is supported by our finding of adhesion molecules on
autopsy valves that were diseased but not stenotic and
therefore not subject to hemodynamic disturbances. We
observed adhesion molecules on tricuspid and bicuspid
valves, suggesting a common mechanism of disease.
The nature of the inflammatory stimulus that may be
involved is not clear. Both diabetes and hyperlipidemia have
been reported as risk factors for AS (15). No reports on the
possible role of micro-organisms have yet been published.
Activated T lymphocytes and macrophages have been dem-
onstrated in degenerative tricuspid AV disease (16), but this
aspect has not been examined in bicuspid aortic valve
disease.
Adhesion molecules were not demonstrated on all of the
degenerative valves studied. This may be due to many
factors. It is possible that degenerative AV disease may have
heterogeneous etiologies where the molecular mechanisms
may vary. Also temporal factors may be responsible, with
expression varying at different stages of the disease process.
Study limitations. We studied segments of the surgically
removed AVs. The expression of adhesion molecules may
not be uniform across the valve, and we could have missed
areas of the valve that had more intense expression of
adhesion molecules. Changes in shear stress are known to
cause changes in adhesion molecule expression (13), and it
is possible that there might have been increased adhesion
molecule expression on aortic endothelium beyond the valve
that we did not sample. We did not study adhesion
molecule expression on circulating leukocytes that are
known to express ICAM-1 and VCAM-1 and could have
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been important sources of soluble ICAM and VCAM-1
formation in our study. The standard deviation for soluble
E-selectin levels was large, particularly in the six month
postoperative samples. However, there was no overlap in the
95% confidence intervals for the means between preoperative
levels when compared with the controls or the 18-month
postoperative levels.
Conclusions and possible clinical implications. This
study has demonstrated for the first time the expression of
the adhesion molecules E-selectin, ICAM-1 and VCAM-1
in degenerative AV disease. Soluble E-selectin levels were
elevated preoperatively, correlated strongly with endothelial
expression and fell significantly 18 months postoperatively.
This suggests that soluble E-selectin levels in peripheral
blood may be useful as a marker of endothelial activation.
These findings support the possibility that inflammation
may play a role in the pathogenesis of the disease. Further
studies exploring the role of cytokines and transcription
factors in the process may refine targets for preventing or
slowing disease progression.
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